Victoria Bunik | Biology | Innovative Research Award

Innovative Research Award

Victoria Bunik

Victoria Bunik
Affiliation Moscow State University
Country Russia
Scopus ID 7003933084
Documents 130
Citations 3,738
h-index 32
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0002-2552-8560

Victoria Bunik is a researcher associated with biological sciences and neurochemical research at Moscow State University. Her scholarly work includes studies on metabolic regulation, mitochondrial biochemistry, neurodegenerative mechanisms, vitamin-dependent biochemical pathways, and molecular neurobiology.[1] Her publications demonstrate sustained contributions to biochemical and neurological research through interdisciplinary scientific investigations involving enzymatic regulation, metabolic disorders, and molecular therapeutic approaches.

Abstract

Victoria Bunik has contributed extensively to biological and neurochemical sciences through research involving mitochondrial metabolism, enzymatic regulation, vitamin-dependent biochemical processes, and neurological disorders. Her publications examine molecular mechanisms associated with epilepsy, neurodegeneration, metabolic adaptation, and cellular signaling pathways.[2] Her interdisciplinary studies integrate biochemical analysis with molecular biology approaches to investigate metabolic homeostasis and neurological function. The research output demonstrates sustained academic engagement in neurochemistry and molecular biology, contributing to scientific understanding of metabolic regulation and potential therapeutic pathways in complex neurological and biochemical disorders.

Keywords

Biology, Neurochemistry, Molecular Biology, Metabolic Regulation, Mitochondrial Biochemistry, Neurological Disorders

Introduction

Modern biological research increasingly focuses on understanding metabolic regulation and molecular signaling in neurological systems. Scientific investigations involving mitochondrial function and vitamin-dependent enzymatic activity are important for advancing biomedical knowledge.[3] Victoria Bunik’s work contributes to this area through studies examining neurochemical and biochemical pathways.

Research Profile

Her research profile reflects extensive publication activity in biology and neurochemistry with an h-index of 32 and more than 3,700 citations. Her academic contributions include journal articles and collaborative studies involving molecular biology, epilepsy research, mitochondrial metabolism, and vitamin-related biochemical regulation.[1]

Research Contributions

Victoria Bunik has contributed to studies involving pyruvate dehydrogenase regulation, protein acylation, epilepsy-related metabolism, and neurochemical responses to vitamins B1 and B6.[4] Her work also includes investigations into glutamate dehydrogenase activity and biochemical markers associated with neurological conditions.

Publications

  • “Pentylenetetrazole-Induced Seizures Are Increased after Kindling.”
  • “Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase.”
  • “Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.”

Research Impact

The research conducted by Victoria Bunik contributes to scientific understanding of neurochemical regulation and metabolic adaptation in neurological systems. Her work has relevance for molecular medicine, neurodegenerative disease research, epilepsy studies, and biochemical therapeutic investigations.[5]

Award Suitability

Victoria Bunik’s sustained publication record, interdisciplinary biological research, and scholarly impact demonstrate suitability for recognition through the Innovative Research Award. Her scientific contributions support continued advancement in neurochemistry, metabolic biology, and molecular biomedical sciences.

Conclusion

The academic work of Victoria Bunik reflects consistent engagement in biological and neurochemical sciences through studies focused on metabolic regulation, molecular signaling, and neurological processes. Her research contributions continue to support scientific progress in molecular biology and neurochemistry.

References

  1. Elsevier. (n.d.). Scopus author details: Victoria Bunik, Author ID 7003 933084. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003933084
  2. Bunik, V. et al. (2023). Pentylenetetrazole-Induced Seizures Are Increased after Kindling. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms241512405
  3. ORCID. (2026). Victoria Bunik Research Record.
    https://orcid.org/0000-0002-2552-8560
  4. Bunik, V. et al. (2022). Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase. Journal of Neurochemistry.
    https://doi.org/10.1111/jnc.15576
  5. Bunik, V. et al. (2010). Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.
    https://doi.org/10.4061/2010/749061

Alisa Kokorina | Biology | Women Researcher Award

Women Researcher Award

Alisa Kokorina

Alisa Kokorina, affiliated with the Skolkovo Institute of Science and Technology, is a researcher recognized for contributions to biology, neurotechnology, and post-COVID-19 clinical outcome research. Her scholarly activities reflect interdisciplinary collaboration involving rehabilitation technologies, neuroscience, and international healthcare consensus studies.[1]

Alisa Kokorina
Affiliation Skolkovo Institute of Science and Technology
Country Russia
Scopus ID 57438603500
Documents 2
Citations 288
h-index 2
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0001-5325-5830

Her publications address rehabilitation science, clinical outcome standardization, and brain-computer interface methodologies. Through participation in international Delphi consensus initiatives, Kokorina has contributed to the development of standardized approaches for studying post-COVID-19 conditions and rehabilitation outcomes.[2]

Abstract

Alisa Kokorina is associated with interdisciplinary scientific research focusing on biology, neurotechnology, and clinical rehabilitation studies. Her scholarly work includes participation in international investigations related to post-COVID-19 condition assessment and the development of standardized clinical outcome sets. She has contributed to research on brain-computer interface technologies and lower limb rehabilitation systems integrating electrical spinal stimulation methodologies. Publications connected to her research profile appear in internationally recognized journals such as The Lancet Respiratory Medicine, BMC Medicine, and Frontiers in Human Neuroscience. These contributions demonstrate collaborative engagement in evidence-based healthcare and rehabilitation science research initiatives.[2]

Keywords

Biology, Neurotechnology, Brain-Computer Interface, Rehabilitation Science, Post-COVID-19 Research, Clinical Outcomes, Neuroscience, Delphi Consensus.

Introduction

The increasing integration of neurotechnology and healthcare analytics has expanded interdisciplinary biomedical research. Alisa Kokorina has participated in collaborative studies involving rehabilitation systems, neuroscience, and post-COVID-19 clinical frameworks. Her research activity reflects the importance of international scientific cooperation in addressing rehabilitation and long-term healthcare challenges.[3]

Research Profile

Kokorina’s academic profile includes publications indexed through ORCID and Scopus databases. Her documented research areas involve neurorehabilitation systems, post-stroke rehabilitation, and consensus-based clinical outcome measurement studies. She is affiliated with international collaborative research involving medical and rehabilitation sciences.[1]

Research Contributions

Among her noted contributions is participation in studies examining core outcome measurement instruments for adults with post-COVID-19 conditions. Additional work explored rehabilitation methods using visuomotor transformation-based brain-computer interfaces and spinal cord electrical stimulation technologies.[4]

Publications

  • Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface, Frontiers in Human Neuroscience, 2026.
  • A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research, Lancet Respiratory Medicine, 2022.
  • Novel method for lower limb rehabilitation based on brain-computer interface and transcutaneous spinal cord electrical stimulation, CNN Conference Proceedings, 2022.

Research Impact

The citation record associated with Kokorina’s research profile indicates scholarly visibility within rehabilitation and biomedical research communities. Her collaborative publications support the advancement of standardized methodologies and interdisciplinary rehabilitation research approaches.[5]

Award Suitability

The Women Researcher Award recognizes emerging and established researchers contributing to scientific innovation and collaborative advancement. Kokorina’s involvement in neurotechnology, rehabilitation science, and post-COVID-19 outcome studies demonstrates interdisciplinary engagement aligned with the objectives of international scientific recognition programs.

Conclusion

Alisa Kokorina’s academic profile reflects contributions to biomedical and rehabilitation sciences through collaborative international research. Her participation in consensus studies and neurotechnology-based rehabilitation investigations highlights ongoing engagement with contemporary healthcare and biological research challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Alisa Kokorina, Author ID 57438603500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57438603500
  2. ORCID. (2026). Alisa Kokorina ORCID Record.
    https://orcid.org/0000-0001-5325-5830
  3. Munblit, D. et al. (2022). A core outcome set for post-COVID-19 condition in adults. Lancet Respiratory Medicine.
    https://doi.org/10.1016/S2213-2600(22)00169-2
  4. Ninenko, I. et al. (2022). Novel method for lower limb rehabilitation based on brain-computer interface.
    https://doi.org/10.1109/cnn56452.2022.9912550
  5. Kokorina, A. et al. (2026). Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface.
    https://doi.org/10.3389/fnhum.2026.1774409

Dimitrios Tsiachris | Medicine | Best Researcher Award

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.